 |
PDBsum entry 2kd3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protein binding
|
PDB id
|
|
|
|
2kd3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Biochem Biophys Res Commun
380:160-165
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
NMR structure of the Wnt modulator protein Sclerostin.
|
|
S.E.Weidauer,
P.Schmieder,
M.Beerbaum,
W.Schmitz,
H.Oschkinat,
T.D.Mueller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Sclerostin has been identified as a negative regulator of bone growth. Initially
it was considered that Sclerostin performs its regulatory function via acting as
a modulator of bone morphogenetic proteins (BMPs) similar to known examples such
as Noggin, Chordin, and members of the DAN family. Recent findings, however,
show that Sclerostin interferes with the Wnt signaling pathway due to binding to
the Wnt co-receptor LRP5 thereby modulating bone growth. As Sclerostin is
exclusively produced by osteocytes located in bones, neutralization of its
bone-inhibiting functions makes it a highly interesting target for an
osteoanabolic therapeutic approach in diseases characterized by bone loss, such
as osteoporosis. Despite the huge interest in Sclerostin inhibitors the
molecular basis of its function and its interaction with components of the Wnt
signaling cascade has remained unclear. Here, we present the NMR structure of
murine Sclerostin providing the first insights how Sclerostin might bind to LRP5.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.T.Shum,
C.Chan,
C.M.Leung,
and
J.A.Tanner
(2011).
Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling.
|
| |
Biochem J,
434,
493-501.
|
 |
|
|
|
|
 |
Z.Cheng,
T.Biechele,
Z.Wei,
S.Morrone,
R.T.Moon,
L.Wang,
and
W.Xu
(2011).
Crystal structures of the extracellular domain of LRP6 and its complex with DKK1.
|
| |
Nat Struct Mol Biol,
18,
1204-1210.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.C.Rider,
and
B.Mulloy
(2010).
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.
|
| |
Biochem J,
429,
1.
|
 |
|
|
|
|
 |
C.Paszty,
C.H.Turner,
and
M.K.Robinson
(2010).
Sclerostin: a gem from the genome leads to bone-building antibodies.
|
| |
J Bone Miner Res,
25,
1897-1904.
|
 |
|
|
|
|
 |
M.J.Moester,
S.E.Papapoulos,
C.W.Löwik,
and
R.L.van Bezooijen
(2010).
Sclerostin: current knowledge and future perspectives.
|
| |
Calcif Tissue Int,
87,
99.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |